![](/img/cover-not-exists.png)
LBA14_PRThe HOBOE-2 multicenter randomized phase III trial in premenopausal patients with hormone-receptor positive early breast cancer comparing triptorelin plus either tamoxifen or letrozole or letrozole + zoledronic acid
Perrone, F, De Laurentiis, M, de Placido, S, Orditura, M, Cinieri, S, Riccardi, F, Ribecco, A S, Putzu, C, Del Mastro, L, Rossi, E, Daniele, B, Mosconi, A M, Di Rella, F, Landi, G, Nuzzo, F, Pacilio,Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy424.003
Date:
October, 2018
File:
PDF, 76 KB
english, 2018